You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API calcipotriene


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing calcipotriene

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
LEO Pharma Inc DOVONEX calcipotriene 50222-260 .ALPHA.-TOCOPHEROL, DL-
LEO Pharma Inc DOVONEX calcipotriene 50222-260 CETETH-20
LEO Pharma Inc DOVONEX calcipotriene 50222-260 CETOSTEARYL ALCOHOL
LEO Pharma Inc DOVONEX calcipotriene 50222-260 DIAZOLIDINYL UREA
LEO Pharma Inc DOVONEX calcipotriene 50222-260 DICHLOROBENZYL ALCOHOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing calcipotriene

Company Ingredient NDC Excipient
Amneal Pharmaceuticals of New York LLC calcipotriene 0115-1475 HYDROXYPROPYL CELLULOSE
Amneal Pharmaceuticals of New York LLC calcipotriene 0115-1475 ISOPROPYL ALCOHOL
Amneal Pharmaceuticals of New York LLC calcipotriene 0115-1475 MENTHOL
Amneal Pharmaceuticals of New York LLC calcipotriene 0115-1475 PROPYLENE GLYCOL
Amneal Pharmaceuticals of New York LLC calcipotriene 0115-1475 SODIUM CITRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for calcipotriene

Excipient focus: .ALPHA.-TOCOPHEROL

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

calcipotriene drug variants containing .ALPHA.-TOCOPHEROL, DL-

Company Ingredient NDC
Sandoz Inc calcipotriene and betamethasone dipropionate 0781-7165
Padagis Israel Pharmaceuticals Ltd calcipotriene, betamethasone dipropionate 45802-816
Padagis Israel Pharmaceuticals Ltd calcipotriene and betamethasone dipropionate 45802-889
Perrigo New York Inc calcipotriene and betamethasone dipropionate 45802-989
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-227
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: ALPHA-TOCOPHEROL, DL-

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTANE

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: BUTYLATED HYDROXYTOLUENE

calcipotriene drug variants containing BUTYLATED HYDROXYTOLUENE

Company Ingredient NDC
Padagis Israel Pharmaceuticals Ltd calcipotriene and betamethasone dipropionate 45802-889
Perrigo New York Inc calcipotriene and betamethasone dipropionate 45802-989
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-227
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-302
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-501
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: CARBOMER INTERPOLYMER TYPE A

Excipient focus: CETETH-20

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CETYL ALCOHOL

Excipient focus: DIAZOLIDINYL UREA

Excipient focus: DICHLOROBENZYL ALCOHOL

Excipient focus: DIISOPROPANOLAMINE

Excipient focus: DIMETHYL ETHER

Excipient focus: EDETATE DISODIUM

Excipient focus: GLYCERIN

Excipient focus: HYDROGENATED CASTOR OIL

calcipotriene drug variants containing HYDROGENATED CASTOR OIL

Company Ingredient NDC
Cosette Pharmaceuticals Inc calcipotriene and betamethasone dipropionate 0713-0848
Padagis Israel Pharmaceuticals Ltd calcipotriene and betamethasone dipropionate 45802-889
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-501
Taro Pharmaceuticals USA Inc calcipotriene and betamethasone dipropionate 51672-1402
Physicians Total Care Inc calcipotriene and betamethasone dipropionate 54868-6091
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: LAURETH-4

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: MENTHOL

Excipient focus: MINERAL OIL

Excipient focus: PETROLATUM

Excipient focus: PHOSPHORIC ACID

Excipient focus: POLOXAMER 407

Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

Excipient focus: POLYPROPYLENE GLYCOL 11 STEARYL ETHER

Excipient focus: POLYPROPYLENE GLYCOL 15 STEARYL ETHER

Excipient focus: PPG-11 STEARYL ETHER

calcipotriene drug variants containing PPG-11 STEARYL ETHER

Company Ingredient NDC
Cosette Pharmaceuticals Inc calcipotriene and betamethasone dipropionate 0713-0848
Perrigo New York Inc calcipotriene and betamethasone dipropionate 45802-989
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-501
Taro Pharmaceuticals USA Inc calcipotriene and betamethasone dipropionate 51672-1402
TOLMAR Inc calcipotriene and betamethasone dipropionate 63646-040
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: PPG-15 STEARYL ETHER

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: STEARETH-2

Excipient focus: STEARYL ALCOHOL

Excipient focus: TROLAMINE

Excipient focus: WATER

calcipotriene drug variants not containing WATER

Company Ingredient NDC
Cosette Pharmaceuticals Inc calcipotriene and betamethasone dipropionate 0713-0848
Sandoz Inc calcipotriene and betamethasone dipropionate 0781-7165
Padagis Israel Pharmaceuticals Ltd calcipotriene and betamethasone dipropionate 45802-889
Perrigo New York Inc calcipotriene and betamethasone dipropionate 45802-989
LEO Pharma Inc calcipotriene and betamethasone dipropionate 50222-227
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group